Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

  1. González Martín, A.
  2. Oza, A.M.
  3. Embleton, A.C.
  4. Pfisterer, J.
  5. Ledermann, J.A.
  6. Pujade-Lauraine, E.
  7. Kristensen, G.
  8. Bertrand, M.A.
  9. Beale, P.
  10. Cervantes, A.
  11. Kent, E.
  12. Kaplan, R.S.
  13. Parmar, M.K.B.
  14. Scotto, N.
  15. Perren, T.J.
Revue:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Année de publication: 2019

Volumen: 152

Número: 1

Pages: 53-60

Type: Article

DOI: 10.1016/J.YGYNO.2018.08.036 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus